11m
HealthDay on MSNOzempic, Wegovy Linked To Potential Vision LossPeople taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye co ...
The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...
Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed the toll up to the end of January with 82 people ...
3h
Hosted on MSNHims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide UpdateHims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...
31m
Axios on MSNCopycat Ozempic makers brace for crackdownMakers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...
WEIGHT-loss drugs can be bought on the black market with no checks or consultation, The Sun has found. We obtained ...
New rules were announced earlier this month over online pharmacies which are prescribing the drugs as 500,000 Britons aid to ...
US FDA declares Wegovy & Ozempic shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses: Plainsboro, New Jersey Monday, February 24, ...
The regulatory agency reported at least 22 fatalities linked to the medication up to the end of January and 60 further deaths ...
The former Love Island star, 30, embarked on a health and fitness transformation before launching her own nutrition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results